Market cap: $9,517,525
Exchange: NAS
Sector: Health Technology
?terna Zentaris, Inc. operates as a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests. Its product Macimorelin, is an oral growth hormone secretagogue receptor agonist indicated for the diagnosis of Adult Growth Hormone Deficiency. The company was founded on September 12, 1990 and is headquartered in Charleston, SC.
Company Name
Aeterna Zentaris Inc.
Average Volume (10 days)
10,019
Average Volume (30 days)
4,625
Moving Average (50 days)
$8.06
Moving Average (200 days)
$7.63
Ex-Divided Date
n/a
Dividend Yield
0
P/E Ratio
0
Market Cap
9,517,525
Shares Outstanding
1,213,970
52-Week High Split Adjust Only
12.8
52-Week Low Split Adjust Only
5.44
Employee Count
47
Beta
0
Next Earnings Date
TTM Dividend Rate Per Share
0
Past 5 days
-0.02%
Past 30 days
-0.06%
Past 3 months
0.09%
Past 6 months
0.27%
Past year
-0.37%
Past 2 years
-0.69%
Past 5 years
-0.98%
Max % Change
-1%
| Name | Ticker | Price/Sales (ttm) | Price/Book (ttm) | Forward P/E | PEG Ratio | EV/Revenue |
|---|---|---|---|---|---|---|
| Aeterna Zentaris Inc. | AEZS | n/a | n/a | n/a | n/a | n/a |
| Peer Avg | N/A | 5.71 | 19.44 | 7.8 | 5.71 | 6.11 |
| Novartis AG - ADR | NVS | 4.37 | 4.32 | n/a | 4.37 | 5.05 |
| Sanofi - ADR | SNY | 2.93 | 1.74 | n/a | 2.93 | 3.17 |
| Bristol-Myers Squibb Co. | BMY | 3.43 | 3.90 | 8.8 | 3.43 | 4.21 |
| Halozyme Therapeutics Inc. | HALO | 17.80 | 87.23 | 30.0 | 17.80 | 18.13 |